Oral evidence transcript
| Published on: | Monday 10 March 2014 |
|---|---|
| Date: | Wednesday 26 February 2014 |
| Meeting on: | Wednesday 26 February 2014 |
| Part of event segment: | Untitled |
| Document ID: | 152953 |
| Citations: |
|
Committees
Work packages
-
Antimicrobial resistance (AMR)
Wednesday 11 September 2013 - Tuesday 21 October 2014
Witnesses
-
Professor Jeremy Farrar, Director, Wellcome Trust, Professor Sir John Savill, Chief Executive Officer, Medical Research Council (representing the Research Councils UK), Kush Naker, Policy and Advocacy Co-ordinator, Universities Allied for Essential Medicines UK, and Professor Sir Anthony Coates, Professor of Medical Microbiology, Antibiotic Discovery UK; Dr Louise Leong, Head of Research and Development, Association of the British Pharmaceutical Industry, James Anderson, Director, European Partnerships, GlaxoSmithKline, Dr David Williams, Chief Executive Officer, Discuva, and Michael McIntyre, Chair, European Herbal and Traditional Medicine Practitioners Association.